Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SOFOSBUVIR\VELPATASVIR Cause Product use issue? 174 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 174 reports of Product use issue have been filed in association with SOFOSBUVIR\VELPATASVIR. This represents 1.0% of all adverse event reports for SOFOSBUVIR\VELPATASVIR.

174
Reports of Product use issue with SOFOSBUVIR\VELPATASVIR
1.0%
of all SOFOSBUVIR\VELPATASVIR reports
1
Deaths
23
Hospitalizations

How Dangerous Is Product use issue From SOFOSBUVIR\VELPATASVIR?

Of the 174 reports, 1 (0.6%) resulted in death, 23 (13.2%) required hospitalization.

Is Product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SOFOSBUVIR\VELPATASVIR. However, 174 reports have been filed with the FAERS database.

What Other Side Effects Does SOFOSBUVIR\VELPATASVIR Cause?

Fatigue (3,666) Headache (3,084) Nausea (1,637) Diarrhoea (882) Insomnia (715) Drug ineffective (694) Product dose omission issue (625) Death (597) Hepatitis c (510) Vomiting (507)

What Other Drugs Cause Product use issue?

INFLIXIMAB (12,752) DUPILUMAB (10,575) POLYETHYLENE GLYCOL 3350 (9,432) METHOTREXATE (8,185) DICLOFENAC (8,009) RITUXIMAB (6,948) ADALIMUMAB (6,379) ETANERCEPT (6,062) TOCILIZUMAB (5,944) ABATACEPT (5,915)

Which SOFOSBUVIR\VELPATASVIR Alternatives Have Lower Product use issue Risk?

SOFOSBUVIR\VELPATASVIR vs SOFOSBUVIR\VELPATASVIR\VOXILAPREVIR SOFOSBUVIR\VELPATASVIR vs SOLIFENACIN SOFOSBUVIR\VELPATASVIR vs SOLIRIS SOFOSBUVIR\VELPATASVIR vs SOLOSTAR SOFOSBUVIR\VELPATASVIR vs SOLRIAMFETOL

Related Pages

SOFOSBUVIR\VELPATASVIR Full Profile All Product use issue Reports All Drugs Causing Product use issue SOFOSBUVIR\VELPATASVIR Demographics